Head of Clinical
Diabetes UK is based in Bethnal Green and Stepney (London)
Cited in UK press coverage of health & social care
5 citations
Across 1 topic, first on 10 Aug 2026, most recently 27 Aug 2026.
Douglas Twenefour is a Specialist Dietitian with over 15 years of clinical experience who serves as Head of Clinical at Diabetes UK, the UK's leading diabetes patient, healthcare professional and research charity. He is also an Associate Lecturer at London Metropolitan University. Twenefour co-chaired the 2018 Diabetes UK nutrition guidelines working group and served as co-chair of the SACN joint working group investigating lower carbohydrate diets for adults with type 2 diabetes. He was a member of the international expert group convened by the American Diabetes Association that produced the consensus report on the definition and interpretation of remission in type 2 diabetes, published across four major journals in 2021. He is regularly quoted in UK press on diabetes treatment access, NICE guidance, and the clinical management of type 2 diabetes.
Cited on
Stated areas of expertise
“For some, especially those with additional care needs, moving from daily insulin injections to a once-weekly option could help manage their diabetes more easily, improving their quality of life.”
head of clinical at Diabetes UK · Diabetes · 27 Aug 2026 · Weekly type 2 diabetes jab could replace daily injections ↗
“For some, especially those with additional care needs, moving from daily insulin injections to a once-weekly option could help manage their diabetes more easily, improving their quality of life.”
Head of clinical at Diabetes UK · Diabetes · 27 Aug 2026 · NICE recommends weekly insulin jab for type 2 diabetes in final draft guidance ↗
“For some, especially those with additional care needs, moving from daily insulin injections to a once-weekly option could help manage their diabetes more easily, improving their quality of life.”
head of clinical at Diabetes UK · Diabetes · 27 Aug 2026 · NICE approves weekly insulin injection for patients with type 2 diabetes ↗
“This recommendation is an important step towards giving people with type 2 diabetes greater flexibility in how their condition is managed.”
head of clinical at Diabetes UK · Diabetes · 27 Aug 2026 · Lilly’s long-acting insulin wins NICE blessing ahead of potential UK approval ↗
Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.
“Around 6.9 million people in the UK are at increased risk of type 2 diabetes, but taking small steps can make a big difference.”
head of clinical at Diabetes UK · Diabetes · 10 Aug 2026 · St Helens residents urged to check their type 2 diabetes risk ↗